Germline ETV6 mutations and predisposition to hematological malignancies

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Autosomal dominant thrombocytopenia, characterized by decreased platelet counts and bleeding tendencies, often presents in childhood.
• Germline mutations in ETV6, RUNX1, or ANKRD26 are implicated in inherited thrombocytopenia syndromes.
• These syndromes are associated with an increased risk of developing myelodysplastic syndrome (MDS) and acute leukemia (AL).

Purpose of the Study:

• To review the role of the ETV6 gene in hematopoiesis, focusing on myeloid differentiation and maturation.
• To describe the functional consequences of mutations in the ETV6 gene.
• To provide an overview of clinical features, screening, and follow-up recommendations for germline ETV6 syndrome.

Main Methods:

• Literature review of reported cases and functional studies related to germline ETV6 mutations.
• Analysis of clinical phenotypes associated with ETV6, RUNX1, and ANKRD26 mutations.
• Discussion of current understanding of ETV6 function in hematopoiesis.

Main Results:

• Germline ETV6 mutations are found in 18 families, presenting with mild to moderate thrombocytopenia.
• A variable predisposition to acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and MDS is observed.
• ETV6 is a crucial hematopoietic transcription factor involved in myeloid differentiation and maturation.

Conclusions:

• Germline ETV6 mutations represent a significant genetic cause of inherited thrombocytopenia with leukemia predisposition.
• Understanding the functional impact of mutant ETV6 is key to managing affected patients.
• Further research may expand the recognized clinical features of germline ETV6 syndrome, guiding improved patient care and surveillance strategies.